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Protein networks in the maturation of human
iron–sulfur proteins
Simone Ciofi-Baffoni, *ab Veronica Nasta ab and Lucia Banci *ab
The biogenesis of iron–sulfur (Fe–S) proteins in humans is a multistage process occurring in different
cellular compartments. The mitochondrial iron–sulfur cluster (ISC) assembly machinery composed of
at least 17 proteins assembles mitochondrial Fe–S proteins. A cytosolic iron–sulfur assembly (CIA)
machinery composed of at least 13 proteins has been more recently identified and shown to be responsible
for the Fe–S cluster incorporation into cytosolic and nuclear Fe–S proteins. Cytosolic and nuclear Fe–S
protein maturation requires not only the CIA machinery, but also the components of the mitochondrial
ISC assembly machinery. An ISC export machinery, composed of a protein transporter located in the
mitochondrial inner membrane, has been proposed to act in mediating the export process of a still
unknown component that is required for the CIA machinery. Several functional and molecular aspects of
the protein networks operative in the three machineries are still largely obscure. This Review focuses on
the Fe–S protein maturation processes in humans with the specific aim of providing a molecular picture
of the currently known protein–protein interaction networks. The human ISC and CIA machineries
are presented, and the ISC export machinery is discussed with respect to possible molecules being the
substrates of the mitochondrial protein transporter.
Introduction
Metal ions are essential for life, with more than one third of
proteins encoded by the human genome depending on metals for
their function.1–3 Nature has built several pathways responsible
for metal handling and metalloprotein maturation in human
cells. A large portion of metalloproteins themselves in the
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human proteome are involved in pathways dedicated to
maintaining the delicate balance between metal uptake and
usage, as essential nutrients, and the excretion of excess metals
thus preventing any potential damage.4–6 Altered or lacking
regulation of these cellular processes can lead to cell toxicity
and death.7–9 Despite the extensive progress in the area of
‘‘metals in biology’’, we still have only a partial understanding
of: (i) how metalloproteins acquire the correct metals/metal
cofactors, (ii) how cells establish and maintain the required
metal levels, (iii) how the maturation of a metalloprotein
occurs, and (iv) how these three aspects intersect each other
and with other cellular processes. A molecular understanding
of the cellular pathways related to all these processes needs to
be thoroughly investigated through the identification and
description of the individual components, of their modes of
interaction to form networks, and of their interlinks among other
cellular pathways. This knowledge provides an inescapable step to
obtain a complete and realistic description of the cellular pro-
cesses related to metals, and is particularly relevant because
several human diseases, including a number of neurodegenera-
tive diseases, cardiovascular disorders and certain types of cancer,
have been associated with the malfunction of metal-based cellular
mechanisms.10–14 A molecular description of the pathways
responsible for obtaining the mature, active forms of metallo-
proteins thus represents an essential step in understanding
the origin of the related human diseases and in developing
effective treatments.
Extensive studies in the past few decades have addressed, at a
molecular level, the cellular pathways related to copper homeo-
stasis and copper enzyme maturation in human cells.5,15–20
Those studies focused on the investigation of the structural
and dynamic properties of proteins involved in copper transport,
of their modes of interaction and of the factors driving copper
transfer between protein partners along cellular routes.21,22
All these studies contributed to a reliable picture of the copper
molecular systems biology in humans. Iron handling in human
cells is by far much more complex than that of copper. The
human iron proteome is, indeed, larger than that of copper,
reflecting its extensive usage in human physiological processes,23–25
and, as a further degree of complexity with respect to copper, iron is
physiologically present in various forms, i.e. either as individual
metal ions or as bound to cofactors, mainly hemes and iron–sulfur
(Fe–S) clusters. The latter are inorganic cofactors that bind to
protein ligands, which, in the majority of the cases, are cysteines.
Common Fe–S clusters include a rhomboid cluster composed of
two iron ions and two inorganic sulfide ions ([2Fe–2S]),26 and a
cubane composed of four iron and four sulfide ions ([4Fe–4S]).27
The [2Fe–2S] cluster can function as the building block to form
[4Fe–4S] clusters. The capability of two rhombic [2Fe–2S] clus-
ters to fuse to form a cubane [4Fe–4S] cluster has been, indeed,
documented in vitro28 and in vivo.29 Much larger and more
complex Fe–S clusters are found in enzymes such as hydro-
genase and nitrogenase, and often also contain other metals,
such as molybdenum.30 The biosynthesis of such complex Fe–S
clusters requires specific maturation machinery for their proper
synthesis and insertion into the enzyme.31
Fe–S clusters are present in all three kingdoms of life.
The most common function of Fe–S clusters is based on their
ability to accept or donate single electrons to carry out complex
enzymatic reactions. This feature differentiates them from non-
metal-containing prosthetic groups, such as NAD+, FMN or
FAD, which are less versatile and are limited to accepting
electron pairs once involved in a redox enzymatic reaction cycle.
Moreover, the fact that electron transfer can occur without under-
going energetically costly protein reorganization32 favours Fe–S
proteins to be responsible for fast electron transfer processes
between different metal centres in large protein complexes.
For example, in complex I of the mitochondrial respiratory chain,
eight Fe–S clusters are positioned close to each other in a quasi-
linear arrangement throughout the protein section that extends
into the mitochondrial matrix.33 The increasing reduction
potentials along the eight Fe–S clusters drive the electron
transfer direction from NADH, a strong electron donor in the
mitochondrial matrix, to ubiquinone, an electron acceptor and
a carrier in the inner mitochondrial membrane.
The function of Fe–S clusters is not limited to electron
transfer. Another well-characterized function of Fe–S clusters
is enzymatic catalysis; a classic example being aconitase, in
which a non-protein-coordinated Fe at one edge of a [4Fe–4S]
cluster serves as a Lewis acid to assist H2O abstraction from
citrate (the substrate), which is converted to isocitrate. Other
well-known Fe–S enzymes are biotin synthase and lipoate
synthase, which bind two Fe–S clusters each. One of these
clusters is disassembled during the formation of the products
biotin and lipoic acid, respectively, thus serving as a sulfur
donor.34 Numerous other catalytic functions are known for
eukaryotic Fe–S enzymes involved in metabolism.35 However,
in many cases, the precise role of the Fe–S cluster is still
unclear, and it is therefore possible that in some proteins the
Fe–S cluster simply plays a structural role.
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A third general role of Fe–S clusters is in sensing environ-
mental or intracellular conditions to regulate gene expression.36
The best characterized example in mammals is provided by the
cytosolic iron regulatory protein 1 (IRP1, also known as ACO1).
Under iron-replete conditions, IRP1 holds a [4Fe–4S] cluster
and functions as an aconitase. When the protein loses its labile
cluster under iron deprivation, it can bind to stem–loop struc-
tures (termed iron-responsive elements (IREs)) in certain
messenger RNAs of proteins involved in iron uptake, storage
and distribution in the cell.37 Binding of apo-IRP1 to 50-located
IREs blocks translation by inhibiting ribosome scanning to the
start AUG codon, whereas the association with 30-located IREs
protects the mRNAs from nucleolytic degradation, leading to
increased translation.
A sequence-based bioinformatic approach38 has been applied
to the human genome to identify the Fe–S proteome. This search
mapped 70 unique genes (i.e. 0.35% of the human genes), with
61% of Fe–S proteins binding [4Fe–4S] clusters, 39% of them
binding [2Fe–2S] clusters and only one (i.e. succinate dehydro-
genase) binding a [3Fe–4S] cluster.39 Experimental verification of
their ability to bind an iron–sulfur cofactor is available for most
of these proteins either directly or by similarity to some close
homologue. From this analysis it also emerges that the number
of mitochondrial Fe–S proteins that bind a [2Fe–2S] cluster is
very close to that of those binding the [4Fe–4S] cofactor.39
Instead, there is a higher number of [4Fe–4S] binding proteins
in the cytoplasm, with the ratio of the [4Fe–4S]/[2Fe–2S] cluster-
binding proteins being close to 2 : 1. Nuclear Fe–S proteins
are almost exclusively of the [4Fe–4S] type, with the above
ratio nearly 5 : 1.39 Finally, the distribution of the identified
human Fe–S proteins within cell compartments shows that the
mitochondrial proteins are inherited from prokaryotic proteins
of aerobes, whereas cytosolic and nuclear Fe–S proteins are
inherited from anaerobic organisms.40
Initially, researchers thought that the Fe–S clusters assemble
spontaneously in vivo, given the fact that chemists are able
to synthesize and to incorporate into proteins various Fe–S
clusters in vitro using elemental iron and sulfur components as
building blocks.28 However, the discovery of a bacterial operon
(nitrogen fixation (nif)) that contains genes associated with the
synthesis of the Fe–S clusters of nitrogenase in the bacterial
plant symbiont Azotobacter vinelandii41 revolutionized the
studies on cellular Fe–S cluster biogenesis. In bacterial DNA,
the genes that function in a pathway are often grouped together
in an operon that facilitates the co-expression of functionally
related proteins. This is the case of the nif operon of A. vinelandii
and of two related operons of Escherichia coli, the iron–sulfur
cluster (isc) and the sulfur formation (suf) operons.26,42 In bacteria,
the Fe–S protein biogenesis machineries were thus straight-
forwardly identified and showed how Fe–S clusters are synthe-
sized and then provided to client proteins in a single cellular
compartment, i.e. the cytoplasm. In mammalian cells, the
synthesis and distribution of Fe–S clusters are more complex.
Mitochondria are the major sites containing Fe–S clusters; the
twelve Fe–S clusters of the respiratory chain complexes I–III and
the Fe–S cluster of aconitase, a component of the citric acid
cycle, are synthetized and incorporated into their respective
mitochondrial proteins by the iron–sulfur cluster (ISC) assem-
bly machinery.43,44 More recently, several cytosolic and nuclear
proteins have been recognized as Fe–S proteins, including DNA
primases, polymerases, and glycosylases, involved in base
excision repair, and helicases, involved in the maintenance of
genome stability.45,46 A cytosolic iron–sulfur assembly (CIA)
machinery has been identified and shown to be responsible
for the Fe–S cluster incorporation into cytosolic and nuclear
Fe–S proteins.47 From the studies of yeast and human cells,48–51
it has been shown that their maturation, however, requires
not only the CIA machinery, but also components of the
mitochondrial ISC assembly machinery. From this finding, it
was proposed that a sulfur-containing compound of still
unknown identity (X–S) is exported from the mitochondria to
the cytoplasm for use in the cytosolic and nuclear compart-
ments of eukaryotic cells.52–54 An ISC export machinery has
been proposed to act in mediating the export process of the X–S
compound.51 The export mechanism is based on a protein
transporter located in the mitochondrial inner membrane, which
has been shown to have a key role for the maturation of the
cytosolic and nuclear proteins.48 However, whether the mitochon-
drial and cytosolic Fe–S cluster assembly pathways are truly
connected in mammals is still debated, and the paradigm that
Fe–S clusters are assembled solely in the mitochondrial matrix
does not necessarily extrapolate to mammalian cells.55,56 Indeed, a
small amount of extra-mitochondrial isoforms of several compo-
nents of the ISC assembly machinery responsible for assembling
Fe–S clusters have been identified,57–61 and there is functional
evidence that one of these components in its cytosolic isoform
functions as a scaffold and a source for extra-mitochondrial
Fe–S clusters in mammalian cells.59
This Review focuses on the Fe–S protein maturation processes
in humans with the specific aim of providing a molecular picture
of the currently known protein–protein interaction networks.
The human ISC and CIA machineries are presented, and the ISC
export machinery is discussed with respect to possible molecules
being substrates of the mitochondrial protein transporter.
The mitochondrial iron–sulfur cluster
(ISC) assembly machinery
The mitochondrial ISC assembly machinery was inherited from
endosymbiotic bacteria during evolution and is highly con-
served in all eukaryotes.62,63 It is the crucial cellular component
required for the maturation of mitochondrial and cytosolic/
nuclear Fe–S proteins.51 In humans, this process encompasses
17 known proteins (Table 1), but the way in which they
cooperate is still not well understood. The overall process can
be dissected into three major functional steps: (i) the assembly
of an initial [2Fe–2S] cluster on a scaffold protein, ISCU2; (ii) a
chaperone-assisted [2Fe–2S] cluster transfer from ISCU2 to
glutaredoxin-5 (GLRX5), which works as a [2Fe–2S] chaperone
transferring the [2Fe–2S] clusters to several possible acceptors;
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target-selective insertion into mitochondrial [4Fe–4S] target
proteins.51,64,65
Assembly of a [2Fe–2S] cluster on the scaffold protein ISCU2
In humans, seven proteins act in the first step of the mitochon-
drial ISC assembly machinery (Table 1), five of them (ISCU2,
NFS1, ISD11, ACP and FXN) forming a stable complex devoted
to forming a [2Fe–2S]2+ cluster by assembling two Fe2+ ions and
two sulfide ions (Fig. 1). Ferrous ions are imported into the
mitochondrion by the intermembrane transporters mitoferrin-
1 and mitoferrin-2 (MFRN1/2) to form a bioavailable iron pool
in the mitochondrial matrix (Fig. 1), in which ferrous ions are
believed to be bound to the still unidentified ligands.66 A recent
approach based on liquid chromatography coupled with induc-
tively coupled plasma mass spectrometry was used to analyse
non-proteinaceous low-molecular-mass metal complexes in
mitochondria.67 It was found that three iron complexes with
masses of 580, 1100 and B1500 Da constitute the mitochondrial
labile iron pool in mammals.68 This iron pool is used by the
scaffold protein ISCU2 to assemble a [2Fe–2S] cluster (Fig. 1).69 It
has been proposed that frataxin is responsible of supplying the
iron to ISCU2, but concrete in vivo evidence of frataxin supplying
iron ions is still lacking.70 It was also shown that the role of
frataxin can go well beyond that of an iron transporter by
working as a regulator of Fe–S cluster assembly.71 The origin
of the two sulfide ions required to build a [2Fe–2S] cluster is
instead clearer. They are indeed provided by the conversion of
two cysteines into alanines. This process is performed by a sub-
complex formed by the cysteine desulfurase NFS1, ISD11 and
ACP proteins (Fig. 1) and requires four electrons. Assuming that
two electrons are supplied by the oxidation of two ferrous
ions,72 two additional electrons from an external source are
required to make a [2Fe–2S]2+ cluster. They are provided by an
electron donor chain formed by two other components acting
in this first step, FDX and FDXR (Fig. 1).
The sub-complex formed by NFS1, ISD11 and ACP proteins
is a symmetric dimer in solution (Fig. 2),73 which is responsible
for the conversion of a cysteine into alanine per each NFS1
subunit. The sulfur atom released from the cysteine is transiently
bound as a persulfide group on a conserved cysteine residue of
NFS1.74,75 NFS1 is formed by two domains, the larger one having a
PLP binding site.73 NFS1 is inactive on its own and needs further
proteins for its functioning, i.e. ISD11 and ACP.57,76,77 ISD11, also
known as LYRM4, belongs to the LYR protein family characterized
by a Leu-Tyr-Arg (LYR) motif near the N-terminus. It has been
shown that the LYR motif and the N-terminus are essential for the
role of ISD11 in the formation of a stable and active complex with
NFS1.78 ISD11 is a small a-helical protein with three helix-forming
regions (Fig. 2);73 and it has been demonstrated that it stabilizes
NFS1 by preventing its self-aggregation through hydrophobic
interactions.76 Recently, the mitochondrial acyl carrier protein
(ACP) has been identified as part of this sub-complex, i.e. in the
absence of ACP, the sub-complex is destabilized resulting in a
profound depletion of Fe–S clusters throughout the cell.77,79,80
This role of ACP depends upon its covalently bound S-dodecanoyl-
40-phosphopantetheine (40-PPT) to support maximal cysteine
desulfurase activity.77 Crystallographic and EM structures of the
co-expressed human NFS1-ISD11 and the E. coli ACP (ACPec 44%
identical to the human mitochondrial ACP) dimeric complex, also
called the SDAec complex, have been solved
73 (Fig. 2). They are
different from any previously determined prokaryotic cysteine
desulfurase structures, identifying the bases for the differences
in prokaryotic and eukaryotic cysteine desulfurase mechanisms.
The SDAec complex shows an unprecedented architecture in which a
pair of ISD11 subunits forms the dimeric core of the SDAec complex,
explaining the critical role of ISD11 in eukaryotic assemblies.
Table 1 Components of the mitochondrial ISC assembly machinery in humans
Short name Full name Functional cofactors Proposed main function
ISC assembly factors involved in de novo Fe–S cluster synthesis
ISCU2 Iron–sulfur cluster assembly enzyme 2 [2Fe–2S] Scaffold protein
NFS1 Cysteine desulfurase PLP Sulfur donor
ISD11 Iron–sulfur protein biogenesis desulfurase-interacting protein 11 — Stabilizer of NFS1
ACP Acyl carrier protein S-dodecanoyl-40-PPT Metabolic sensor
FXN Frataxin Fe2+ Iron donor, regulator of NFS1
FDX Ferredoxin [2Fe–2S] Electron transfer
FDXR Ferredoxin reductase FAD Electron transfer
ISC factors involved in cluster transfer
GRP75 75 kDa glucose-regulated protein ATP Fe–S cluster transfer
HSCB Iron–sulfur cluster co-chaperone protein — Fe–S cluster transfer
GRPEL1/2 GrpE protein homolog 1/2 — Nucleotide exchange
GLRX5 Glutaredoxin-5 [2Fe–2S], GSH Fe–S cluster transfer
Late-acting ISC factors involved in assembly and the insertion of Fe–S clusters into the target proteins
ISCA1 Iron–sulfur cluster assembly 1 homolog [2Fe–2S], [4Fe–4S] [4Fe–4S] cluster assembly
ISCA2 Iron–sulfur cluster assembly 2 homolog [2Fe–2S], [4Fe–4S] [4Fe–4S] cluster assembly
IBA57 Iron–sulfur cluster assembly factor — [4Fe–4S] cluster assembly
NFU1 Iron–sulfur cluster scaffold [4Fe–4S] Dedicated ISC targeting factor
BOLA3 BolA-like protein 3 — Dedicated ISC targeting factor
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The structure also reveals that the 40-PPT-conjugated acyl-group
of ACP occupies a hydrophobic pocket of ISD11, explaining the
basis of ACP stabilization (Fig. 2).73
The [NFS1ISD11ACP] sub-complex can bind ISCU2 in the
presence or absence of FXN.81,82 Binding of FXN to the sub-complex
accelerates desulfurase activity81 and persulfide formation on NFS1,
and is also thought to induce a conformational change in
ISCU2 that enhances the transfer of sulfur from NFS1 to Cys
138 of ISCU2, the primary persulfide acceptor of ISCU2.83–85
The mechanism of sulfur transfer from the persulfide group on
the conserved cysteine residue of NFS1 to the Fe–S cluster
assembly site of ISCU2 involves the flexible loop of NFS1
containing the invariant cysteine residue.81,86,87 Ferrous ions
further stimulate the cysteine desulfurase activity.81
The human ISCU protein has two different isoforms, ISCU1
and ISCU2, with different subcellular locations. It has been found
by immunofluorescence microscopy that ISCU1 is localized to
the cytosol and nucleus, whereas ISCU2 is localized to the
mitochondria, being part of the ISC assembly machinery.88
Also human frataxin has two different isoforms, FXN42–210
Fig. 1 A model for the maturation of human mitochondrial and cytosolic/nuclear Fe–S proteins. The mitochondrial ISC assembly machinery can be
dissected into three major steps. In the first step, a [2Fe–2S]2+ cluster is assembled on the scaffold protein ISCU2. This reaction requires the complex
formed by NFS1, ISD11, FXN and ACP, and the electron transfer chain composed by FDX and FDXR, which receives two electrons from NADPH. The
conversion of two (2) cysteines to alanines provides the two sulfur atoms required to assemble the [2Fe–2S]2+ cluster. Two ferrous ions imported into
the mitochondrion by the intermembrane transporters MFRN1/2 are used to assemble the [2Fe–2S]2+ cluster. In the second step, the [2Fe–2S]2+ cluster
is released from ISCU2 to GLRX5, an event that is mediated by a dedicated chaperone system (GRP75, HSCB, and GRPEL1-2). The [2Fe–2S]2+ cluster can
then be inserted into mitochondrial [2Fe–2S] target proteins. An alternative model suggests that ISCU2 can directly insert the [2Fe–2S]2+ cluster on the
mitochondrial [2Fe–2S] target proteins without involving GLRX5, and that it can assemble and insert a [4Fe–4S]2+ cluster into the mitochondrial [4Fe–4S]
target proteins (bold dashed lines). In the third step, ISCA1, ISCA2 and IBA57 proteins contribute to convert a [2Fe–2S]2+ cluster into a [4Fe–4S]2+ cluster,
which then is inserted into the mitochondrial [4Fe–4S] target proteins with the possible help of various ISC targeting factors, i.e. NFU1, NUBPL and
BOLA3. [[2Fe–2S] BOLA1 GLRX5] and [[2Fe–2S] BOLA3 GLRX5] complexes can potentially play a role in the maturation of mitochondrial [4Fe–4S] target
proteins. The CIA machinery requires the mitochondrial ISC assembly machinery, which produces a still unidentified compound X–S that is exported
from mitochondria by the ISC export machinery (composed of ABCB7 and GSH). This compound might be used to assemble [2Fe–2S]2+ clusters on the
GLRX3 homodimer (or the [GLRX3 BOLA22] heterotrimer). The [2Fe–2S]2
2+ GLRX32 homodimers (and/or the [[2Fe–2S]
2+ GLRX3 BOLA22] heterotrimers)
insert their [2Fe–2S]2+ clusters into cytosolic [2Fe–2S] target proteins, such as Anamorsin, or, possibly, into the [NUBP1 NUBP2] heterotetrameric or
heterodimeric complex to assemble a [4Fe–4S]2+ cluster. In such a molecular model, the electron transfer chain composed of NADPH, NDOR1 and
Anamorsin provides the two electrons required for the reductive coupling of two [2Fe–2S]2+ clusters on the [NUBP1 NUBP2] complex. This complex then
transfers the assembled [4Fe–4S]2+ cluster to the carrier NARFL, which transfers it into cytosolic and nuclear [4Fe–4S] target proteins. The latter process
is assisted by the CIA targeting complex [CIAO1 CIA2B MMS19] or by the [CIA2A CIAO1] complex, and by the [YAE1D1 ORAOV1] complex. Protein colour
code: grey, Fe–S target proteins; yellow, scaffold proteins; blue, membrane carriers; green, proteins involved in electron transfer and sulfide production;
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and FXN81–210, with the 81–210 isoform being the most abundant
species in normal individuals.89 Both are generated and localized
within the mitochondria,89 and participate in the mitochondrial
Fe–S cluster assembly using different modes of interaction with
NFS1, ISD11 and ISCU2 as well as different iron binding
capacities.90 These isoforms are generated through the sequential
cleavage of the FXN protein precursor (FXN 1-210) by the mito-
chondrial processing peptidase upon import of FXN 1-210 to
the mitochondrial matrix.91–93 As determined by size-exclusion
chromatography of normal human cell extracts, the native state of
FXN42–210 is a monomer–oligomer equilibrium, whereas the native
state of FXN81–210 is monomeric.94 Complexes containing oligo-
meric FXN42–210, NFS1, ISD11 and ISCU2 could be isolated upon
fractionation of normal human cell extracts by size-exclusion
chromatography followed by co-immunoprecipitation,94–96
underscoring the stability of these complexes. In contrast,
native FXN81–210 was only recovered in fractions that contained
no detectable NFS1 and only traces of ISCU2. However, a
[FXN81–210NFS1ISD11ISCU2] complex has been isolated from
bacterial cells upon the co-expression of all four components of
the complex, and it could also be reconstituted in vitro from the
purified [NFS1ISD11ISCU2] complex and the FXN81–210 monomer.
However, in both cases, a large excess of monomeric FXN81–210 was
required for complex formation,82,97 which may explain why this
complex could not be detected under native conditions in human
cells.94,95 On the basis of differentiated iron binding abilities of
the two FXN isoforms under aerobic conditions,81,95,97 it has been
proposed that, under physiological conditions, FXN81–210 may
bind low levels of iron and support basal levels of Fe–S cluster
assembly via transient interactions with the [NFS1ISD11ISCU2]
complex. While the stable [FXN42–210NFS1ISD11ISCU2] complex
may provide a mechanism to increase the rate of Fe–S cluster
assembly when the demand exceeds the low iron-binding capacity
of FXN81–210.90
Recently, isolation, biochemical and structural characteriza-
tion of the human Fe–S cluster assembly complex containing
most of the proteins of the first step of the mitochondrial ISC
assembly machinery (ISCU2, NFS1, ISD11 and FXN42–210) has
been reported (Fig. 2).98 The structural data provided a first
model of a coordinated mechanism for the transfer of iron and
sulfur to ISCU2 for the synthesis of a [2Fe–2S]2+ cluster. It was
shown that these four human proteins, once co-expressed in
E. coli cell extracts, form a stable, active complex with a 1 : 1 : 1 : 1
stoichiometry. This complex may also contribute to explain how
human frataxin may serve as both the activator of NFS1 and the
iron donor, an argument still largely debated in the literature.51,99
Indeed, in the context of the human [FXN81–210NFS1ISD11ISCU2]
complex having the shorter FXN isoform,97 one monomer of
FXN81–210 is thought to bind in a pocket between NFS1 and
ISCU2 through the conserved frataxin iron-binding surface,97,100
in such a way to block the ability of FXN81–210 to bind iron and
thus contrasting with its role in iron delivery. In contrast, the
location of ISCU2 relative to FXN42–210 and NFS1 in the human
[FXN42–210NFS1ISD11ISCU2] structure allows FXN42–210 and
NFS1 to simultaneously bind to ISCU2 and to stimulate Fe–S
cluster synthesis, consistent with the previous observation that
ISCU2 and [NFS1ISD11] can independently or simultaneously
bind to oligomeric FXN42–210 in solution.101
The electron transfer chain formed by ferredoxin (FDX) and
ferredoxin reductase (FDXR), which receives an electron from
NADH, accomplishes the task of providing the two electrons
required to form a [2Fe–2S]2+ cluster on ISCU2 (Fig. 1).80 In human
mitochondria, there are two different isoforms of ferredoxins,
FDX1 and FDX2. Their X-ray structures are very similar even
if the two ferredoxins share only 33% protein sequence identity
(Fig. 2).80 By NMR spectroscopy, it has been demonstrated that
both FDX1 and FDX2 interact directly with the [NFS1 ISD11
ACP] sub-complex and that their reduced forms, when added to
Fig. 2 Structural overview of the early steps of the human mitochondrial iron–sulfur cluster (ISC) assembly machinery. The [2Fe–2S]2+ cluster
biosynthesis is performed by a protein complex composed of NFS1, ISD11, ACP, FXN and ISCU2. The structure of this complex has been solved in pieces:
the crystal structure of the [NFS1 ISD11 ACP] complex (PDB ID 5USR) and the cryo-EM structure of the [NFS1 FXN ISCU2] complex (PDB ID 5KZ5). For the
electron transfer chain composed of FDX and FDXR, the X-ray structure of FDX is available (PDB ID 2Y5C). For the subsequent step consisting of the
chaperone-mediated transfer of the assembled [2Fe–2S]2+ cluster from ISCU2 to GLRX5, structural information are available on some single players only:
the crystal structures of the Zn-bound HSCB protein (PDB ID 3BVO), of the SBD (PDB ID 3N8E) and ATPase domains (PDB ID 4KBO) of GRP75, and of the
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a solution of the complex and L-cysteine, become oxidized,
indicating that both ferredoxins are able to donate electrons
leading to the reduction of the sulfur atom. Despite the fact
that both FDX isoforms interact with the [NFS1 ISD11 ACP] sub-
complex, FDX2 exhibits both a higher binding affinity for the
complex and a much higher efficiency in assisting the Fe–S
cluster assembly. Functional data indicated that only FDX2 is
part of the electron transport chain required for de novo
mitochondrial Fe–S protein biogenesis, while FDX1 is essen-
tially devoted to the steroid metabolism in the adrenal gland.102
In contrast to this view, the RNA interference-mediated depletion
of either FDX1 or FDX2 was reported to impair Fe–S protein
maturation.103 An in vitro reconstitution system containing
the yeast ISC members of the first step of the ISC assembly
machinery showed that the yeast orthologue of FDX2, Yah1, in a
reduced but not oxidized state tightly interacts with apo-Isu1
indicating a dynamic interaction between Yah1-apo-Isu1.104
Nuclear magnetic resonance structural studies identify the
Yah1-apo-Isu1 interaction surface and suggest a pathway for
the electron flow from reduced Yah1 to Isu1.104
A chaperone-assisted [2Fe–2S] cluster transfer from ISCU2 to
glutaredoxin-5
In the second step, the de novo assembled [2Fe–2S]2+ cluster is
released from the scaffold protein ISCU2 to the monothiol
glutaredoxin GLRX5. This event is mediated by a dedicated
chaperone system comprising the GRP75 chaperone (also
named mortalin, HSPA9 or PBP74), which is a member of the
ATP-dependent 70-kDa heat shock protein family Hsp70, its
co-chaperone HSCB (also named HSC20), and the nucleotide
exchange factors GRPEL1/2 (Table 1 and Fig. 1).105 The actual
molecular model is based on the initial binding of the HSCB
protein to [2Fe–2S] ISCU2, which then forms a complex with
the chaperone GRP75.105–107 NMR data indicated that a con-
formational change of ISCU2 occurs upon HSCB binding,
which specifically weakens the [2Fe–2S] ISCU2 interaction in
the [FXNACPNFS1ISD11ISCU2] complex, and strengthens its
interaction with the co-chaperone HSCB, which targets the
[2Fe–2S] [ISCU2 HSCB] complex to the chaperone GRP75.108
The C-terminal a-helical domain of the HSCB co-chaperone
(Fig. 2) is directly responsible for binding ISCU2, with three
highly conserved non-contiguous hydrophobic residues being
of crucial importance for the HSCB–ISCU2 interaction.44,109–112
The N-terminal domain of HSCB (Fig. 2), which contains an
invariant histidine, proline, and aspartate motif, is responsible
for stimulating the ATPase activity of the GRP75 chaperone.
Overall, the HSCB co-chaperone might have a dual function in
stimulating the ATPase activity of the chaperone GRP75 and in
promoting its recognition between ISCU2 and the chaperone
GRP75. The N-terminus of the human HSCB co-chaperone
shows distinctive features compared to the homologous
co-chaperone proteins of bacteria and fungi (DnaJ type III), as
it contains, downstream of the mitochondrial targeting sequence
(residues 1–26), an additional domain, which harbors two CxxC
stretches (C41/C44 and C58/C61) that were found to coordinate a
zinc ion in vitro (Fig. 2).112 The physiological relevance of the
unique N-terminal domain remains to be elucidated although it
may facilitate protein dimerization.
As for all Hsp70 family chaperones, GRP75 is composed of
two domains, the crystal structures of them being determined:
a B42 kDa N-terminal ATP-binding domain and a B25 kDa
substrate-binding domain (SBD) involved in the ISCU2 recogni-
tion (Fig. 2).113 The two domains of GRP75 do not interact with
each other but are tethered by a short interdomain linker. The
sequence of the ATP-binding domain is highly conserved in all
Hsp70 family members, while the SBD has several differences
among family members. The ADP dissociation step on GRP75 is
facilitated by the nucleotide exchange factors GRPEL1/2. Such
dissociation enables GRP75 to undergo the next round of Fe–S
cluster transfer. The ATP-binding domain of GRP75 is found to
interact with the nucleotide exchange factors.114
On the basis of studies on the yeast Grx5 homologue,115–117
and considering that the Grx5 function is conserved throughout
the eukaryotic kingdom,118–120 it has been proposed that GLRX5
mediates [2Fe–2S] cluster transfer from the [HSCB GRP75 [2Fe–2S]
ISCU2] complex to [2Fe–2S] target proteins and to intermediate
proteins responsible for the assembly of [4Fe–4S] clusters (Fig. 1).
GLRX5 in solution binds a [2Fe–2S] cluster forming a [2Fe–2S]2+
cluster-bridged homodimer with two glutathione (GSH) molecules
involved in cluster binding (Fig. 2).121 Gel filtration and 15N NMR
relaxation data on the holo and apo states of GLRX5 showed that
cluster binding induces a change in the quaternary structure from
an apo-monomer to a holo dimer.121 The dimeric state of [2Fe–2S]
GLRX5 prevents the cluster from being released in the presence
of physiological concentrations of GSH, suggesting that GLRX5
can specifically transfer the cluster.
Recent studies have shown that the HSCB co-chaperone
in the [HSCB GRP75 [2Fe–2S] ISCU2] complex can guide the
selection of specific Fe–S recipient proteins for cluster delivery by
binding to a conserved LYR motif present in specific proteins.122
In this regard, the best-characterized example is the succinate
dehydrogenase subunit b (SDHB), which is the Fe–S cluster-
containing subunit of the respiratory complex II.106 This protein
contains three independent LYR binding sites, all close to the
cysteines that coordinate the three Fe–S clusters of SDHB and in
a position where the binding of the chaperone/co-chaperone
[2Fe–2S] transfer apparatus can guide the release of the cluster
from [2Fe–2S]–ISCU2 into the Fe–S binding sites of SDHB. The
LYR motif family is present only in eukaryotes (conserved
domains accession: cl05087),123 which lists other proteins related
to the mitochondrial Fe–S protein biogenesis in humans, thus
potentially being the HSCB-dependent recognition mechanism
conserved in other Fe–S target insertion processes. One of the
members of the LYR family is SDHAF1 (LYRM8), a succinate
dehydrogenase complex assembly factor.124 SDHAF1 was shown
to recruit the [HSCB GRP75 ISCU2] complex to the C-terminus of
SDHB through direct binding of its N-terminal LYR motif to the
HSCB co-chaperone.125 Another LYR protein is LYRM7, a complex
III assembly factor,126 which interacts with the [HSCB GRP75
ISCU2] complex,106 suggesting that the LYRM7–HSCB interaction
might guide the insertion of the [2Fe–2S] cluster into the Rieske
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present in the mitochondrial complex I, and one of these has
been suggested to be required for the proper incorporation of
the N2 [4Fe–4S] center and for the function of complex I.123
A second consensus sequence, in addition to the LYR motif, is
the KKx6–10KK motif, which has been found to interact with the
HSCB co-chaperone.106 GLRX5 has a similar pattern of lysines
at its C-terminus (K139K140x10K151K152) and has been found to
interact with HSCB in vivo.106 All these findings suggest that the
model in which GLRX5 is the central component for distributing
[2Fe–2S] clusters to final [2Fe–2S] acceptors and to the proteins
involved in the late steps of the mitochondrial ISC assembly
machinery for maturing [4Fe–4S] target proteins might have to
be revisited. Indeed, GLRX5 could be just one among the LYR and
KKx6–10KK targets of the [HSCB GRP75 [2Fe–2S] ISCU2] complex,
which, in contrast, could be the real distributor of [2Fe–2S]
clusters (Fig. 1). However, there are several pieces of evidence
that this new possible model is not able to answer. Among
them, how [4Fe–4S] clusters are formed and inserted into the
mitochondrial target proteins is fully undefined by this model. It
has been shown, indeed, that the mammalian Fe–S assembly
complex (i.e. the [FXNACPNFS1ISD11ISCU2] complex) is able to
synthesize exclusively [2Fe–2S] clusters.127 Therefore, the way that
the [4Fe–4S] and [3Fe–4S] clusters of LYR-containing targets of
the [HSC20 GRP75 [2Fe–2S] ISCU2] complex (i.e. mitochondrial
respiratory complexes I–III) are formed, is still not addressed in
this possible alternative model.
Reductive coupling of two [2Fe–2S]2+ clusters to form a
[4Fe–4S]2+ cluster on ISCA proteins
Among the GLRX5 protein partners,121,128,129 two A-type Fe–S
proteins named ISCA1 (iron–sulfur cluster assembly 1) and
ISCA2 (iron–sulfur cluster assembly 2) are required for mito-
chondrial [4Fe–4S] protein maturation.130,131 ISCA1 and ISCA2
have been first proposed to function in concert with IBA57 to
mature [4Fe–4S] proteins.130 However, the molecular relation
between IBA57 and ISCA proteins has been recently debated.
Indeed, while ISCA1 and ISCA2 are protein partners in vivo,
IBA57 has been found to interact in vivo with ISCA2 but not with
ISCA1, in contrast to what occurs for the yeast homologues,
which both interact with Iba57.132 Surprisingly, it has been
recently observed that only ISCA1 is required for the maturation
of mitochondrial [4Fe–4S] proteins.128 A possible explanation
for the differently observed ISCA2 phenotypes is that different
mammalian cells and conditions were used in the two pheno-
typing experiments,128,130 and thus further in vivo data are
required to resolve this matter. In vitro data133,134 support a model
where a [ISCA1 ISCA2] complex converts [2Fe–2S]2+ clusters,
received by GLRX5, into a [4Fe–4S]2+ cluster, with IBA57 not being
required in this process (Fig. 1). In agreement with this model,
it has been shown that GLRX5 can transfer a [2Fe–2S] cluster
to a heterodimeric complex formed by human ISCA1 and
ISCA2 through a cluster-mediated protein–protein interaction
event,121,133 and that this complex acts as an assembler of a
[4Fe–4S]2+ cluster through a reductive coupling process of two
[2Fe–2S]2+–GLRX5 donated clusters (Fig. 3).133 In the latter
reaction, dithiothreitol provides the two electrons required
for the reductive coupling process. How these electrons are
provided in vivo is still an open question. Finally, although
ISCA2 alone can also bind a [4Fe–4S] cluster in a dimeric state,
it has been observed that the formation of a heterodimeric
[ISCA1 ISCA2] complex is thermodynamically favoured com-
pared to the corresponding homodimeric forms, indicating
that, at the cellular level, the heterodimeric complex should
be the preferential species responsible of assembling [4Fe–4S]2+
clusters. This is in full agreement with the strong, specific
interaction between ISCA1 and ISCA2 observed in vivo.128
Fig. 3 Structural overview of the late steps of the human mitochondrial iron–sulfur cluster (ISC) assembly machinery. In the late steps of
the mitochondrial ISC assembly machinery, the [ISCA2 ISCA1] heterodimeric complex assembles a [4Fe–4S]2+ cluster by the reductive coupling of
two [2Fe–2S]2+ clusters received by GLRX5.133 No evidence on the functional role of IBA57, which is part of this process, is available, nor is the
physiological donor of the two electrons required in the [2Fe–2S] coupling process. NFU1 and NUBPL assist in the maturation of specific [4Fe–4S] target
proteins, but how they work mechanistically in such a process is still undefined. [2Fe–2S] GLRX5 by interacting with BOLA1 and BOLA3 can be converted
into [[2Fe–2S] BOLA1 GLRX5] and [[2Fe–2S] BOLA3 GLRX5] complexes, respectively, but their potential role in the maturation of specific [4Fe–4S] target
proteins is not defined (dotted lines). The solution NMR structures of the C-domain (PDB ID 2M5O) and the N-domain (PDB ID 2LTM) of apo-NFU1,
BOLA1 (PDB ID 5LCI) and BOLA3 (PDB ID 2NCL) have been solved. Experimentally-driven docking models of the two heterodimeric [BOLAs GLRX5]
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Recently, a molecular picture of how the [4Fe–4S] cluster has
been assembled on the heterodimeric [ISCA1 ISCA2] complex
has been provided.134 In this model, the two fully conserved
C-terminal cysteines, located in the unstructured and flexible
C-terminal tail of the ISCA proteins,133 are required to extract
the [2Fe–2S]2+ cluster from GLRX5, while the other fully con-
served cysteine of ISCAs, Cys 79, is not essential for the cluster
transfer step. This cysteine is required to promote the acquisi-
tion of the second [2Fe–2S]2+ cluster from another GLRX5
molecule via C-terminal cysteines of ISCAs, in such a way that
the reductive coupling between the two [2Fe–2S]2+ clusters can
occur on the [ISCA1 ISCA2] complex. This molecular model
agrees with the in vivo data on yeast, which showed that the
three conserved cysteines of yeast Isa1 and Isa2 are essential for
the maturation of [4Fe–4S] proteins.135,136
Target-selective insertion of the assembled [4Fe–4S] cluster into
mitochondrial [4Fe–4S] target proteins
The [4Fe–4S] cluster assembled on the [ISCA1 ISCA2] complex is
inserted into mitochondrial [4Fe–4S] target proteins with the
possible assistance of dedicated ISC targeting factors, i.e. NFU1,
BOLA3 and NUBPL (also named IND1) (Table 1). Specifically,
some mitochondrial [4Fe–4S] target proteins could acquire
their [4Fe–4S] cluster directly from the [ISCA1 ISCA2] complex,
whereas others may derive their clusters after a prior transfer of
the [4Fe–4S] cluster from the [ISCA1 ISCA2] complex to NFU1
and NUBPL. The latter can bind a [4Fe–4S] cluster, which
facilitates the insertion of the cluster into specific mitochon-
drial [4Fe–4S] target proteins (Fig. 1).137–140 In particular, NFU1
acts as a late-acting factor that transfers the [4Fe–4S] clusters to
the lipoic acid synthase and to the subunits of respiratory
complexes I and II, facilitating their maturation,137,138 while
NUBPL works as an assembly factor for the human respiratory
complex I only.140 NFU1 was detected as an ISCA1 specific
interacting partner only.128 However, in yeast, Nfu1 physically
interacts with both Isa1 and Isa2 in the [Isa1 Isa2 Iba57]
complex and with mitochondrial target proteins that need
[4Fe–4S] clusters to function.141 The yeast data suggest that
human NFU1 might specifically bind to the mitochondrial
[4Fe–4S] target proteins independent of the [ISCA1 ISCA2] complex.
Then, the binding of this complex with the [ISCA1 ISCA2]
complex may serve to recruit the NFU1-associated [4Fe–4S] target
proteins to the [ISCA1 ISCA2] complex, specifically assisting
cluster transfer and insertion into these target proteins. As other
possible model, NFU1 was proposed to be an alternative scaffold
to ISCU2, thanks to its ability to assemble [4Fe–4S] clusters and
transfer them to apo-proteins, thus operating upstream of the
[ISCA1 ISCA2] complex.58 Human NFU1 comprises two domains:
an N-terminal domain and a C-terminal domain, which contains
the CXXC motif involved in [4Fe–4S] cluster binding (Fig. 3).58,142
While apo-NFU1 is largely monomeric in solution, [4Fe–4S]
NFU1 consists of a trimer of dimers, with three [4Fe–4S] clusters
bound by the two conserved cysteine residues in the CTDs
of two NFU1 subunits forming the dimer.142 The functional
relevance of the binding of three [4Fe–4S] clusters in a single
aggregate is still unknown.
The phenotypic similarity between the pathogenic muta-
tions of NFU1 and of another mitochondrial protein named
BOLA3 suggests that the two proteins function together in the
late steps of the mitochondrial Fe–S protein maturation path-
way (Fig. 1).137,138 Using yeast as a model system, it has been
proposed that the yeast ortholog of human BOLA3 functions in
the late step of transfer of [4Fe–4S] clusters to specific target
proteins, together with yeast Nfu1.141 Despite the fact that yeast
BolA3 and Nfu1 both act late in the mitochondrial Fe–S protein
biogenesis, they appear to fulfil different tasks that cannot be
taken over by the other protein.143 Proteomic studies did not
detect any stable in vivo interaction between yeast Nfu1 and
BolA3, suggesting a transient interaction in nature; in vitro this
interaction has been found to have a mM affinity.143 Overall,
these results in yeast might suggest that BOLA3 might function
with NFU1 in the cluster insertion into specific mitochondrial
[4Fe–4S] target proteins (Fig. 1), but this mechanism is still
largely hypothetical. BOLA3 belongs to the highly conserved
BOLA-like protein family, which also includes the human
mitochondrial BOLA1.144 Recently, it has been shown in yeast
that the yeast homolog BolA1 also facilitates the insertion of
[4Fe–4S] clusters into a subset of mitochondrial target proteins,
being unable to replace Nfu1, similarly to what occurs with
BolA3 (Fig. 1).143 Even though BolA1 and BolA3 play some
overlapping roles, their functions are not identical.143 The
solution structures of BOLA3 and BOLA1 showed that they have
a similar fold, but with local structural differences in the regions
containing conserved sequence patterns comprising cluster
ligands.143 It has been demonstrated that both BOLA1 and
BOLA3 interact with apo-GLRX5 with Kd values of 3 mM and are
able to form [2Fe–2S] cluster-bridged dimeric hetero-complexes
with GLRX5.141,143 The [[2Fe–2S] BOLA1 GLRX5] complex is
preferentially formed over the [[2Fe–2S] BOLA3 GLRX5] complex,
because of a higher cluster-binding affinity.145 Experimentally
driven structural models and spectroscopic data of these two
heterodimeric holo complexes145 (Fig. 3) showed that: (i) cluster
solvent accessibility is higher in the BOLA3 hetero-complex with
respect to that in the BOLA1 heterocomplex; (ii) the [BOLA1
GLRX5] complex stabilizes a reduced, Rieske-type [2Fe–2S]1+
cluster, while an oxidized, ferredoxin-like [2Fe–2S]2+ cluster is
present in the [BOLA3 GLRX5] complex; (iii) the [2Fe–2S] center in
the [BOLA1 GLRX5] complex behaves like a stable redox active
center able to perform electron transfer reactions, at variance
with what occurs for the [[2Fe–2S] BOLA3 GLRX5] complex. This
experimental evidence suggests that the [[2Fe–2S] BOLA1 GLRX5]
complex might work in electron transfer reactions, while the
[[2Fe–2S] BOLA3 GLRX5] complex might be involved in iron–
sulfur cluster transfer processes versus target proteins along the
Fe–S protein assembly pathway.145 In conclusion, the molecular
scenarios of NFU1 and BOLA3 (alone or complexed with GLRX5)
proteins acting late in the ISC pathway are still largely undefined,
as well as the role of BOLA1 (alone or complexed with GLRX5)
as the possible further ISC late-acting factor is still indefinite.
The other known targeting factor, NUBPL, is another
[4Fe–4S] cluster binding protein, specifically required for the
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sequence to two cytosolic P-loop NTPases, NUBP1 and NUBP2,
which act as a heteromeric scaffold complex in the synthesis
of cytosolic [4Fe–4S] clusters (see later). It contains a highly
conserved nucleotide binding domain and a Fe–S binding
CPXC motif, which is required for the function of NUBPL
and is proposed to provide the ligands for a transiently bound
[4Fe–4S] cluster, probably inducing protein dimerization.140
The cytosolic iron–sulfur assembly
(CIA) machinery
Up to now, thirteen CIA components participating in the
maturation of human cytosolic and nuclear Fe–S proteins have
been identified (Table 2).47,146,147 Most of these components
are conserved in almost all eukaryotes.39,148 Six of these pro-
teins act in the early stage of the CIA machinery, while all the
others are late-acting CIA factors (Table 2).
The assembly of a [4Fe–4S] cluster in the early stage of the CIA
machinery
The early stage of the CIA machinery involves two P-loop NTPase
proteins, named NUBP1 and NUBP2 in humans (also known as
NBP35 and CFD1, respectively). NUBP1 and NUBP2 are nuclear and
cytosolic localized proteins containing several cysteine residues at
their C- and N-termini.149,150 Sequence alignment of NUBP1 and
NUBP2 with their respective eukaryotic homologues identified,
in NUBP1, an invariant N-terminal Cx13Cx2Cx5C motif, which
is absent in the NUBP2 family, and, in NUBP2, an invariant
C-terminal Cx18Cx2Cx2C motif, which is partially conserved or
totally absent in the NUBP1 family depending on the organism.
In the yeast homologues, each of these two motifs binds a
[4Fe–4S] cluster, such that the N-terminal domain is tightly
bound, while that in the C-terminus is labile.151–153 No structural
models of the cluster bound forms of NUBP1 and NUBP2 or
of any eukaryotic homologues are available. This piece of
information would be fundamental to address definitively how the
two proteins bind the [4Fe–4S] cluster(s). Co-immunoprecipitation
shows that the two proteins interact in the cellular context,
suggesting that NUBP1 and NUBP2 proteins cooperate in the
same molecular process of the CIA machinery.149 In vitro and
in vivo studies on the yeast homologous heterocomplex suggest
the presence of bridging [4Fe–4S] clusters in a heterodimeric or
heterotetrameric structural arrangement and that this complex
performs a scaffold function by assembling a [4Fe–4S] cluster
on the C-terminal motif in the early stage of the CIA machinery
(Fig. 4).152,154 This function should be conserved in humans.
Indeed, depletion of NUBP1 by RNA interference in HeLa cells
resulted in a severe defect in the assembly of cytosolic and
nuclear Fe–S proteins without an apparent effect on mitochon-
drial Fe–S protein maturation.149 However, how this hetero-
complex works in the CIA machinery as a scaffold protein
is unknown. The donors of Fe2+ and sulfide ions required to
assemble a [4Fe–4S] cluster on the heterocomplex are not
defined yet, nor are the cluster binding properties of the human
heterocomplex well addressed. Since some early ISC compo-
nents and the membrane transporter of the ISC export machin-
ery are required for the functioning of the CIA machinery in
yeast,48,50,155,156 it might be speculated that the sulfide ions for
assembling the [4Fe–4S] cluster on the heterocomplex require
the mitochondria-exported X–S compound.
The formation of the [4Fe–4S] cluster on the heterocomplex
also requires electrons, and NADPH might provide these via the
NDOR1 and Anamorsin CIA components (Fig. 1). Similar to the
[NUBP1 NUBP2] complex, they operate indeed in the early stage
of the CIA pathway by forming a stable complex.157,158 According
to this proposal, a relatively weak, but specific interaction
between NUBP1 and Anamorsin, compared to the much stronger
interaction between NDOR1 and Anamorsin, has been detected
from yeast-two-hybrid and surface plasmon resonance experi-
ments in plants.159 Although plants lack the NUBP2 gene, thus
not fully representing a fully reliable model for the molecular
Table 2 Components of the CIA machinery in humans
Short name Full name Functional cofactors Proposed main function
Early-acting CIA factors involved in Fe–S cluster assembly and transfer
NUBP1 Nucleotide-binding protein 1 [4Fe–4S] Scaffold protein
NUBP2 Nucleotide-binding protein 2 [4Fe–4S] Scaffold protein
NDOR1 NADPH-dependent diflavin oxidoreductase 1 FAD, FMN Electron transfer
Anamorsin Anamorsin [2Fe–2S], [4Fe–4S] Electron transfer
GLRX3 Glutaredoxin-3 [2Fe–2S], GSH Fe–S cluster transfer, iron trafficking
BOLA2 BolA-like protein 2 — Fe–S cluster transfer
Late-acting CIA factors involved in transfer and insertion of Fe–S clusters into the target proteins
NARFL Fe–S cluster assembly factor [4Fe–4S] Mediates contact between the early and late parts
of the CIA machinery
CIAO1 Cytosolic iron–sulfur protein assembly — CIA targeting complex
CIA2B Mitotic spindle-associated MMXD complex
subunit MIP18
— CIA targeting complex
MMS19 Nucleotide excision repair protein homolog — CIA targeting complex
CIA2A MIP18 family protein FAM96A — Specific maturation factor of IRP1
YAE1D1 Yae1 domain-containing protein 1 — Specific maturation factor of the cytosolic ABCE1 protein
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events in the human CIA machinery, the plant NUBP1 protein
has a scaffold function similar to that of the human [NUBP1
NUBP2] complex.160
NDOR1 is a diflavin reductase consisting of two domains:
the first binds FMN (FMN-binding domain, hereafter), and
the second binds FAD and NADPH (FAD-binding domain,
hereafter) (Fig. 4). On the basis of the well-known electron
transfer mechanism occurring in diflavin reductase enzymes,161
the electrons are transferred from NADPH to FAD and then to
FMN, which serves as a donor for one-electron terminal acceptors,
i.e. the Fe–S cluster(s) of Anamorsin in this case. Anamorsin
contains two domains: an N-terminal domain of 172 residues
and a C-terminal domain of 90 residues, named cytokine-induced
apoptosis inhibitor 1 (CIAPIN1 hereafter), containing two highly
conserved, cysteine-rich motifs, CX8CX2CXC and CX2CX7CX2C
(Fig. 4). An unstructured and flexible linker of 51 residues
connects the two domains (Fig. 4). While the N-terminal domain
is well-structured, the C-terminal CIAPIN1 domain is largely
unstructured (Fig. 4).162 The CIAPIN1 domain of Anamorsin
binds a [2Fe–2S] cluster in the first motif and a [2Fe–2S] or
[4Fe–4S] cluster on the second motif depending on how the
preparation of the protein sample has been conducted
in vitro.163–165 To definitively define which is the physiologically
relevant cluster bound to the second motif of Anamorsin, an
in vivo approach would be required to define the cluster bound
state of Anamorsin in the cellular context. The crystal structure
of the FMN-binding domain of NDOR1 showed the classical
fold of FMN-binding domains of diflavin reductases (Fig. 4).166
The crystal167 and solution162 structures of the N-terminal domain
of Anamorsin (Fig. 4) showed an overall structure resembling a
typical S-adenosylmethionine (SAM)-dependent methyltransferase
fold but lacking the glycine-rich motif, which is typically respon-
sible for the binding of the SAM cofactor in methyltransferases.
As a result, Anamorsin does not show SAM-dependent methyl-
transferase activity.162 On this basis, it has been hypothesized
that the N-terminal domain of Anamorsin acts as bait for
protein–protein interactions. A structural model of the CIAPIN1
domain shows that the CX8CX2CXC and CX2CX7CX2C regions are
connected by a stably formed a-helix and sample a restricted
range of conformations that bring the two cluster-binding motifs
close to each other (Fig. 4).166 Anamorsin and NDOR1 form a stable
complex, thanks to the specific protein–protein recognition
between the FMN-binding domain of NDOR1 and the unstructured
linker region of Anamorsin separating the N-terminal domain from
the C-terminal CIAPIN1 domain (specifically, residues 185–223).166
The N-terminal domain of Anamorsin is not involved in such a
recognition process. The two protein partners interact permanently
forming also a stable interaction in the cell,157 and no dissociation
occurs during the electron transfer process.166 One electron
transfer reaction was observed to occur from the hydroquinone
Fig. 4 Structural overview of the human cytosolic iron–sulfur assembly (CIA) machinery. The tetrameric [NUBP1 NUBP2] complex might receive
electrons from the NADPH-NDOR1-Anamorsin electron transfer chain to assemble a [4Fe–4S]2+ cluster on the C-terminus by reductively coupling two
[2Fe–2S]2+ clusters. These might be received by the holo forms of the GLRX3 and/or [BOLA2 GLRX3] complex. The assembled [4Fe–4S]2+ cluster is
transferred to NARFL, which then delivers it to cytosolic and nuclear target proteins with the contribution of several other CIA proteins. Three of them,
CIAO1, MMS19 and CIA2B, form a complex (CIA targeting complex) assisting the transfer of the [4Fe–4S] cluster from NARFL to the majority of cytosolic
and nuclear target proteins. The complex between CIAO1 and CIA2A specifically matures the cytosolic aconitase/IRP1, while a complex between the CIA
targeting complex and the [ORAOV1 YAE1D1] complex specifically assists the maturation of the ABCE1 protein. The crystal structures of the single
domains of apo-GLRX3 (the Trx domain PDB ID 2WZ9, the GrxA domain PDB ID 3ZYW and the GrxB domain PDB ID 2YAN), of the FMN-binding domain
of NDOR1 (PDB ID 4H2D) and of CIAO1 (PDB ID 3FMNO) have been solved. Two different crystal structures of CIA2A are available (PDB ID 3UX2 and
3UX3); only one of them is shown in the figure. A homology model of BOLA2 was generated based on the available solution structure of the BOLA-like
protein from Mus musculus (PDB ID 1V9J, sequence identity is 87%). A structural model of the [2Fe–2S] CIAPIN1 domain was calculated using
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state of the FMN moiety of NDOR1 to the oxidized [2Fe–2S]2+
cluster bound to the first motif of Anamorsin (N-terminal [2Fe–2S]
cluster), while the Fe–S cluster bound to the second motif of
Anamorsin does not receive electrons from FMN.163
The [Anamorsin NDOR1] complex might therefore supply
electrons to the [NUBP1 NUBP2] complex, working similarly
to the NADPH–FDX–FDXR electron transfer chain in the mito-
chondrial ISC assembly machinery.104 However, at variance
with the ISC assembly machinery, the specific molecular targets
of the electron transfer flow generated by the [Anamorsin NDOR1]
complex are not identified yet. Depending on the molecular
nature of the mitochondria-exported X–S compound, the complex
might reduce the sulfur moiety of the X–S compound to sulfide,
similar to the function of the NADPH–FDX–FDXR electron
transfer chain in the mitochondrial ISC system,155,156 with the
function of building a [2Fe–2S] cluster, and/or it could facilitate
the fusion of two [2Fe–2S] clusters to a [4Fe–4S] cluster. The yeast
homologues of NDOR1 and Anamorsin (named Tah18 and Dre2,
respectively) have been shown not to be involved in the de novo
formation of a [2Fe–2S] cluster.157 Assuming that the same holds
in human cells, we could speculate that the electron transfer
chain composed of NADPH–NDOR1–Anamorsin is involved in
the fusion of two [2Fe–2S]2+ clusters to a [4Fe–4S]2+ cluster on the
[NUBP1 NUBP2] complex. The X–S compound, which is needed
for the CIA machinery function, should therefore operate
upstream of the [NUBP1 NUBP2] complex, to build a [2Fe–2S]
cluster, and therefore an alternative cytosolic pathway for the
de novo synthesis of [2Fe–2S] clusters might be required. Some
ISC components have been detected in small amounts in the
cytosol and in the nucleus, being proposed to function in these
compartments to assemble a [2Fe–2S] cluster,55,59 which is then
used by the CIA machinery for the maturation of cytosolic and
nuclear [4Fe–4S] proteins. However, evidence for a direct func-
tion of these extra-mitochondrial ISC proteins in Fe–S protein
assembly is still under debate.50,151,168
Cytosolic [2Fe–2S] cluster trafficking by glutaredoxin-3 and
BOLA2 protein
Another [2Fe–2S] cluster protein operating in the early stage of
the CIA machinery is the cytosolic monothiol glutaredoxin
GLRX3 (Fig. 1).169 GLRX3 consists of an N-terminal thioredoxin
(Trx) domain that lacks a redox-active motif and two monothiol
glutaredoxin (Grx) domains that both harbor a Cys-Gly-Phe-Ser
active site.170 Crystal structures of the three single domains (Fig. 4)
showed that their overall fold is very similar to that of other
known monothiol glutaredoxins/thioredoxins. Upon [2Fe–2S]
cluster binding, GLRX3 forms a dimeric complex bridging
two [2Fe–2S] clusters between each of the two Grx domains
([2Fe–2S]2 GLRX32, Fig. 4).
171,172 Each cluster is shared by the
cysteine residue of the active site of each Grx domain and by a
GSH molecule per each Grx domain (Fig. 4). Yeast has two
homologous proteins of GLRX3, Grx3 and Grx4, which, similar
to GLRX3, act in cytosolic/nuclear Fe–S protein maturation.173
Yeast Grx3 and Grx4 contain an N-terminal Trx domain, similar to
GLRX3, but only one Grx domain, which binds one [2Fe–2S] cluster
in a dimeric complex similarly to what occurs in GLRX3.174
In yeast, the binding/assembly of the [2Fe–2S] cluster in Grx3
requires the mitochondrial ISC assembly and export machi-
neries, yet occurs independent of the two CIA proteins Nbp35
and Dre2.173,174 Conversely, Fe–S cluster binding on both Nar1
and Dre2 strictly depends on Grx3, placing Grx3 early in the CIA
pathway. Applying this yeast model to humans, GLRX3 might
be the primary target of the X–S compound after its exit from
the mitochondria (Fig. 1). This compound might determine the
formation of the [2Fe–2S] cluster bound state of GLRX3, which
might then act as a cytoplasmic [2Fe–2S] cluster trafficking
protein in the early phase of the CIA pathway (Fig. 1), in analogy
to the proposed function of mitochondrial GLRX5. Now, the
arising question is how GLRX3 is reconstituted with [2Fe–2S]
clusters. The crucial point to provide the answer is the identifi-
cation of the chemical nature of the X–S compound.
The first evidence showing that GLRX3 can work as a [2Fe–2S]
cluster trafficking protein came from an in vitro study.175 Indeed,
it was shown that GLRX3 matures Anamorsin by transferring two
[2Fe–2S] clusters to the cysteine-rich motif of the CIAPIN1
domain (Fig. 1). Anamorsin and GLRX3 are protein partners in
the cellular context as identified by the yeast-two-hybrid assay.176
It was shown that the transfer mechanism was dependent on
the formation of a specific protein–protein complex between
the N-terminal domains of GLRX3 and of Anamorsin, with part
of the linker of Anamorsin having a further, specific role in
stabilizing the interaction.175 Their interaction is the funda-
mental requisite to observe the transfer of both [2Fe–2S]
clusters from Grx domains of GLRX3 to the two cluster-binding
motifs of the CIAPIN1 domain of Anamorsin. In conclusion,
GLRX3 plays a key role in maturing Anamorsin, specifically
working as an intracellular [2Fe–2S] cluster-trafficking protein.
This indirectly links GLRX3 to all Anamorsin-dependent cellu-
lar processes. In vivo data showed that silencing of human
GLRX3 expression in HeLa cells decreased the activities of the
cytosolic Fe–S proteins IRP1 and GPAT.169 This behavior can
be interpreted as an impairment of the GLRX3-dependent
Anamorsin maturation process, making the CIA machinery
unable to function, since it lacks the electron transfer chain
required to form [4Fe–4S] clusters on the [NUBP1 NUBP2]
complex. Similarly, in vivo data in yeast173 showed a decrease
of Fe–S cluster insertion levels into cytosolic [4Fe–4S] target
proteins upon Grx4 depletion. Deficiency in yeast Grx3/4 also
leads to the impairment of the cytosolic ribonucleotide reduc-
tase (RNR) enzyme despite cytosolic iron overload.173 Similar to
the CIA machinery, the maturation of the di-iron cofactor of
RNR depends on the Dre2-Tah18 electron transfer chain,177,178
but iron loading into RNR does not require Dre2, while it requires
Grx3/Grx4 proteins.179 On this basis, an iron-trafficking function
of cytosolic monothiol glutaredoxins can also be proposed.
According to this view, the depletion of GLRX3 in humans and
of Grx3 or Grx4 in yeast specifically also impaired the synthesis of
heme.173 However, direct evidence showing that monothiol Grx
proteins are able to transfer iron ions from the bound [2Fe–2S]
clusters to target proteins is still missing, and such data would
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GLRX3 forms a complex in vitro with the cytosolic protein
BOLA2.171,180 Specifically, the in vitro studies showed that an
apo-complex is formed, with each Grx domain of apo-GLRX3
binding a BOLA2 molecule to form a heterotrimeric complex
(Fig. 1).180 This apo-complex is able to bind two [2Fe–2S]2+
clusters by chemical reconstitution, with each cluster being
bridged between BOLA2 and a Grx domain of GLRX3 ([[2Fe–2S]2
GLRX3 BOLA22], Fig. 4).
171 The same cluster binding state (i.e.
two [2Fe–2S] clusters per trimer) is observed once the hetero-
trimeric complex was isolated by cells co-expressing the two
BOLA2 and GLRX3 proteins.171,180 The [GLRX3 BOLA2] complex
was also observed in mammalian cells.181 This complex is,
however, not as abundant as apo-form in mammalian cells,
likely due to the low protein–protein affinity (Kd = 25 mM), but it
accumulates upon [2Fe–2S] cluster binding, which stabilizes its
interaction.181 In vitro studies180 showed that the [[2Fe–2S]2
GLRX3 BOLA22] complex transfers both its [2Fe–2S]
2+ clusters
to apo-Anamorsin producing its mature holo state (Fig. 1
and 4). The mechanism of cluster transfer relies on the inter-
action between the N-terminal domain of Anamorsin with that
of GLRX3, similarly to what was observed in the cluster transfer
from [2Fe–2S]2 GLRX32 to apo-Anamorsin. In vivo studies con-
firmed that this direct [2Fe–2S] cluster transfer process occurs
in mammalian cells upon complex formation between [[2Fe–2S]
GLRX3 BOLA2] and [apo-Anamorsin NDOR1] complexes.181
Collectively, the experimental data suggested that the hetero-
trimeric complex can work as a [2Fe–2S] cluster transfer compo-
nent in the CIA machinery, similarly to what the homodimeric
[2Fe–2S]2 GLRX32 does (Fig. 1). Now, the arising question is
whether and how the cells handle homodimeric [2Fe–2S]2
GLRX32 and heterotrimeric [[2Fe–2S]2 GLRX3 BOLA22] complexes,
i.e. which is the predominant species acting as a [2Fe–2S] cluster
chaperone at the cellular level. In vivo data181 support a model in
which the heterotrimeric [[2Fe–2S]2 GLRX3 BOLA22] complex is
the species transferring the [2Fe–2S] clusters under physiological
conditions. However, we cannot exclude that, in human cells, the
[2Fe–2S]2 GLRX32 homodimers transfer their own clusters to a
number of target proteins larger than the [[2Fe–2S]2 GLRX3
BOLA22] hetero-complex and, in doing so, they do not accumulate
to a detectable degree in cells. Consistent with this hypothesis, the
bridged clusters in the GLRX3 homodimer were labile in vitro,
much more than in the [[2Fe–2S]2 GLRX3 BOLA22] complex,
171,182
which, conversely, accumulates in human cells.181 In the
hypothesis that the [[2Fe–2S]2 GLRX3 BOLA22] complex works as
the major species in the cytoplasm of human cells transferring the
clusters to several target proteins, we would expect similar effects
on the in vivo Fe–S cluster loading into several target proteins by
deleting BOLA2 or GLRX3, besides Anamorsin. We believe that
such in vivo studies would help in further elucidating the role of
the [[2Fe–2S]2 GLRX3 BOLA22] complex as the cytoplasmic
distributor of [2Fe–2S] clusters. In such studies, alternative
sources of Fe–S cluster loading into the target proteins might
be operative and need to be taken into account. This is indeed
what occurs for Anamorsin, where significant amounts of
residual iron are retained in Anamorsin complexes in the cells
lacking GLRX3 or BOLA2.181 The mitoNEET/miner1 family of
[2Fe–2S] proteins has been proposed to be an alternative source
of Anamorsin for acquiring [2Fe–2S] clusters, since mitoNEET/
miner1 proteins can transfer their [2Fe–2S] clusters to
apo-Anamorsin in vitro,183 and human mitoNEET can transfer
[2Fe–2S] clusters to apo-proteins in the cells exposed to oxida-
tive stress.184–186 This alternative source of Fe–S clusters could
also account for the relatively milder phenotypes associated
with the depletion of GLRX3 in mammalian cells versus yeast,
which does not have mitoNEET homologues. However, the role
of the mitoNEET/miner1 family in the CIA machinery is
still controversial, since still there is no clear evidence from
functional and interactomic data supporting the role of this
protein family in cluster transfer under physiological conditions.
In conclusion, the [2Fe–2S]2+ GLRX32 homodimer and/or
the [[2Fe–2S]2 GLRX3 BOLA22] heterotrimer might work as
cytoplasmic [2Fe–2S] chaperones inserting [2Fe–2S]2+ clusters
into cytosolic [2Fe–2S] target proteins, such as Anamorsin, or
into the [NUBP1 NUBP2] heterotetrameric complex to assemble
a [4Fe–4S]2+ cluster (Fig. 1).
Target-selective insertion of the assembled [4Fe–4S] cluster into
cytosolic/nuclear [4Fe–4S] target proteins
The late steps of the CIA machinery are quite complex and
involve the majority of the CIA proteins. Several studies in the
past few years investigated how these proteins work, all show-
ing that the principal component of this process is a stable
complex composed of three proteins, [CIAO1 MMS19 CIA2B],
commonly named the ternary CIA targeting complex (Fig. 1).187,188
MMS19 contains several HEAT repeats, which are commonly
involved in protein–protein interactions. CIA2B (also named
FAM96B or MIP18) and CIAO1 (also named CIA1) interact with
the C-terminal HEAT repeats of MMS19 to form a docking site for
the majority of cytosolic and nuclear [4Fe–4S] target proteins.189
CIA2B directly interacts with the C-terminal HEAT repeats of
MMS19, while CIAO1 requires the presence of CIA2B for a
stable interaction with MMS19. The direct interaction of
MMS19 with the C-terminus of CIA2B protects CIA2B from
proteosomal degradation.189 A structural analysis of the CIA
targeting complex will be of fundamental relevance for under-
standing whether the interaction between MMS19 and CIAO1 is
solely mediated by CIA2B or whether CIAO1 displays a weak
affinity for MMS19 that is greatly enhanced by CIA2B. Such
structural investigation will also be able to clarify which
domains/proteins are in direct physical contact with cytoplasmic
and nuclear [4Fe–4S] target proteins. The most straightforward
model is that MMS19, CIA2B and CIAO1, jointly, form a docking
site for the [4Fe–4S] target proteins, but we cannot exclude that
the formation of the ternary complex induces a conformational
change in one of the proteins that exposes an interaction site
for the [4Fe–4S] target proteins, otherwise not accessible. The
majority of the [4Fe–4S] target proteins bind the CIA targeting
complex only in the presence of all three proteins of the
complex, i.e. MMS19, CIA2B and CIAO1.189 The only exception
is the transcription factor XPD, which binds to the N-terminal
HEAT repeats of MMS19 independent of CIA2B and CIAO1.189
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interaction sites with the CIA targeting complex: one with the
N-terminus of MMS19 and one with the ‘‘canonical’’ [4Fe–4S]
docking site at the C-terminus of MMS19 that depends on
CIA2B and CIAO1. The only structure available among the
proteins of the CIA targeting complex is the crystal structure
of CIAO1, solved at a resolution of 1.7 Å, showing a b-propeller
fold with seven pseudo-symmetrically orientated blades around
a central axis (Fig. 4).190 This doughnut-shaped geometry is
highly conserved among the large family of WD40 proteins,
which serve as docking sites in a multitude of cellular networks
and mediate the molecular recognition of partner proteins
mainly through the top and side surfaces.191
In addition to the cytosolic and nuclear Fe–S target proteins,
the CIA targeting complex interacts with another CIA compo-
nent, the NARFL protein (also named IOP1) (Fig. 1).192,193
NARFL has been proposed to also interact with the [NUBP1
NUBP2] complex because of the specific interaction between
NUBP2 and NARFL.194 NARFL can thus function at the interface
between the [NUBP1 NUBP2] complex and the CIA targeting
complex in the CIA pathway, but its precise molecular role
remains to be elucidated (Fig. 1). The protein NARFL exhibits a
sequence homology to bacterial [FeFe] hydrogenases,195,196 yet
the absence of hydrogenase activity in yeast suggests that,
instead of a [4Fe–4S] cluster linked to the Fe2(CO)3(CN)2
active-site cluster, NARFL only retains the [4Fe–4S] cluster.197
Nevertheless, NARFL coordinates two [4Fe–4S] cofactors that
are similar to those in hydrogenases.197–199 Studies on the yeast
homolog Nar1 showed that these clusters are bound to the
N- and C-terminal motifs with four conserved cysteine residues
each.197,198 Homology modelling and stability studies suggested
that the C-terminal cluster is buried in the protein and that the
more labile N-terminal cluster is surface-exposed, thus poten-
tially being transferred to protein partners.197,198 Both motifs are
crucial for the function of NARFL as CIA component.198 In yeast,
the depletion of all four early-acting CIA factors (Cdf1, Nbp35,
Tah18, and Dre2) impairs the Fe–S cluster incorporation
into Nar1 in vivo.152,157,197 Conversely, depletion of Nar1 has
no influence on the Fe–S cluster assembly on Cfd1, Nbp35, or
Dre2, but Nar1 is required for the maturation of cytosolic and
nuclear [4Fe–4S] target proteins. In contrast, none of the late-
acting CIA factors are required for the [4Fe–4S] cluster assembly
on Nar1.188,200 Protein interaction studies indicated that Nar1
interacts with the yeast homologues of CIAO1 and CIA2B
(Cia1 and Cia2, respectively),200,201 i.e. with the CIA targeting
complex, as observed for the human homologues. Assuming
that most of the in vivo findings on yeast hold in human cells,
the most reliable model is that the CIA targeting complex binds
NARFL, and that the full complex (the CIA targeting complex +
NARFL) may catalyse the late CIA reactions transferring
[4Fe–4S] clusters, received by the [NUBP1 NUBP2] complex, to
the majority of cytosolic and nuclear [4Fe–4S] target proteins
(Fig. 1 and 4). As a result, it might be possible that the observed
NARFL–NUBP2 interaction,194 discussed above, originates both
from the maturation of NARFL processed by the early-acting
CIA components, and from the [4Fe–4S] cluster transfer from the
[NUBP1 NUBP2] complex to an already matured (i.e. containing
the C-terminal cluster only) NARFL protein bound to the CIA
targeting complex.
NARFL has also been found to be a protein partner of
another late-acting CIA component, i.e. the CIA2A protein
(also named FAM96A), which, in turn, forms a complex with
CIAO1 (Fig. 1 and 4).202 The [CIAO1 CIA2A] complex has been
proposed to be implicated in the [4Fe–4S] cluster maturation of
exclusively IRP1, although no direct interaction with IRP1 was
detected, possibly because of a rather labile interaction between
apo-IRP1 and the [CIAO1 CIA2A] complex.202 An NMR solution
structure of a monomeric form of human CIA2A203 and two
different crystal structures of dimeric CIA2A forms204 have been
reported (Fig. 4). So far, the available structural information has
not provided any decisive insights into the molecular function of
CIA2A. A cysteine residue appears to perform a crucial role in the
CIA2A function for maturing Fe–S target proteins.205 Elucidation
of the molecular role of this reactive cysteine residue might
clarify not only the role of CIA2A but also that of the entire CIA
targeting complex in Fe–S protein maturation.
In conclusion, the proposed model assumes NARFL as the
CIA component distributing [4Fe–4S] clusters assembled on the
[NUBP1 NUBP2] complex to [CIAO1 CIA2A] and CIA targeting
complexes. However, since NARFL cannot replace the cellular
function of Nar1 in yeast,197 more robust data need to be provided
to prove the existence of a physical interaction between NARFL
and the [NUBP1 NUBP2] complex.
Recently, two newly identified CIA factors, termed ORAOV1
and YAE1D1, were shown to function as specific adaptors
connecting the CIA targeting complex with a specific [4Fe–4S]
target protein, a cytosolic ABCE1 protein (Fig. 4). YAE1D1 and
ORAOV1 form a complex that, in turn, interacts with the CIA
targeting complex.193 Both proteins contain an evolutionary
conserved deca-GX3 motif of 40 residues that is not found in
any other eukaryotic protein.193 ORAOV1 additionally carries a
conserved C-terminal tryptophan (phenylalanine in some
organisms).193 A chain of binding events facilitates efficient
ABCE1 maturation: (i) the CIA targeting complex interacts with
ORAOV1 in the [YAE1D1 ORAOV1] complex via its C-terminal
tryptophan; (ii) the two deca-GX3 motifs are crucial for [YAE1D1
ORAOV1] complex formation; (iii) YAE1D1 in the [YAE1D1
ORAOV1] complex mediates contact with the ABCE1 protein.193,206
Interestingly, a characteristically different but related maturation
strategy is followed by the radical-SAM Fe–S enzyme, viperin, an
interferon-induced antiviral defense component.207 This pro-
tein also uses its conserved C-terminal tryptophan to directly
associate with the CIA targeting complex. The removal of this
residue abolishes complex formation with the CIA targeting
complex, the assembly of viperin’s Fe–S cluster, and, conse-
quently, the antiviral function.207 Although it has been reported
that CIAO1 forms mutually exclusive complexes with either
CIA2A or CIA2B,202 in a very recent work investigating the
maturation pathway of the [4Fe–4S] cluster protein viperin, it
has been found that both CIA targeting complex and CIA2A
interact with viperin.208 Specifically, the CIA targeting complex
interacts with the C-terminus of viperin, while CIA2A with the
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CIAO1 is required for the Fe–S cluster incorporation into
viperin. The role of all the other interacting components is still
unclear, but it might be possible that a concerted mechanism
of cluster insertion is operative, in which CIAO1 is the essential
component as it drives the association of all the other
interactors.
The mitochondrial iron–sulfur cluster
(ISC) export machinery
The main component of the mitochondrial ISC export machinery
is an inner membrane ABCB transporter belonging to the
ABCB7 group (Fig. 1).48,209 This group includes the human
ABCB7, yeast Atm1 and Arabidopsis thaliana ATM3 transporters
and can be found in virtually all eukaryotic species and in some
bacterial organisms. In vivo data indicate that the members
of this subfamily have the same function.209–211 In a variety of
organisms, this transporter specifically supports the maturation
of cytosolic and nuclear Fe–S proteins.48,209,211,212 Its depletion
is also associated with defects in cellular iron homeostasis
resulting in cytosolic iron deficiency and a concomitant iron
accumulation in the mitochondria, that is, a similar phenotype
observed for the proteins involved in the early stage of ISC
protein deficiencies.48,213
The other well-established component of the ISC export
machinery is glutathione, which has been found to be essential
for the maturation of extra-mitochondrial Fe–S proteins and for
iron regulation.52,214 It was observed that GSH molecules can
form an in vitro tetra-GSH-coordinated [2Fe–2S] cluster (defined
as (GS)4–[2Fe–2S]).
215–217 The (GS)4–[2Fe–2S] complex is shown
to significantly stimulate the ATPase activity of an ABCB7-type
transporter in both solution and proteoliposome-bound forms.
On the basis of this in vitro evidence, it has been suggested that
the (GS)4–[2Fe–2S] complex is the molecule transiting from the
mitochondria to the cytosol being the physiological substrate
of the membrane transporter.218,219 On the other hand, the
ATPase activity of the purified, liposome-integrated membrane
transporter can be stimulated by many thiol-containing com-
pounds including GSH and GSSG (the oxidized form of GSH),53
questioning the physiological relevance of such an in vitro
approach. In particular, the stimulatory effect of (GS)4–[2Fe–2S]
was 30-fold weaker than that observed with Cys-containing small
peptides. Moreover, the affinity of (GS)4–[2Fe–2S] binding to
Atm1 was in the same range as that of GSH alone, questioning
again the specificity of the (GS)4–[2Fe–2S] interaction with Atm1
in vitro.218–220 Furthermore, it still needs to be documented that the
(GS)4–[2Fe–2S] complex remains intact under physiological trans-
port conditions, and to verify the existence of a (GS)4–[2Fe–2S]
complex in a living cell. In conclusion, it is possible and reasonable
that the (GS)4–[2Fe–2S] complex is the substrate of the membrane
transporter, but further experimental data are required to defini-
tively confirm this conclusion.
The crystal structures of free and glutathione-bound Atm1
were solved and they are virtually identical.219 The main out-
come of the structure is that a V-shaped molecule enclosing a
6900 Å3 positively charged cavity is present. The cavity is close
to the hydrophilic phase of the matrix side of the inner
membrane, and likely serves as the substrate-binding site.
The fact that Atm1 and a related bacterial ABC transporter219
bind GSH or its derivatives suggests that these transporters
may exhibit a similar substrate specificity. Both proteins bind
GSH or its derivatives in the putative substrate-binding pocket
comprised by the large, positively charged cavity close to the
internal membrane surface and near to the putative exit
channel formed by the twelve trans-membrane helices of
Atm1. The cavity features much more space than that occupied
by GSH alone, and therefore it is reasonable to suggest that GSH
is a part of a larger Atm1 substrate and is required for substrate
binding. In agreement with GSH being directly involved in the
substrate export process, the Atm1-deficient mitochondria show
an increased content of GSH,221 and the ATPase activity of Atm1
is stimulated by GSH.53 In particular, the largest stimulation of
ATP hydrolysis by Atm1 from Novosphingobium aromaticivorans
was observed for the Ag and Hg complexes of GSH.222 In the
crystal structure of Atm1 from Novosphingobium aromaticivorans,
an oxidized glutathione molecule, GSSG, is bound into the
transmembrane region in a location similar to GSH, suggesting
that this interaction is specific and that this region of Atm1
family members may allow the binding of a GSH-containing
substrate. Another study has suggested the molecule GSSSG, i.e.
formed by the oxidized form of GSSH (glutathione persulfide)
and GSH, as the Atm1 substrate and a potential sulfur carrier.223
In conclusion, the putative Atm1-like substrate is currently
under debate. The identification on the nature of the molecule
exported from the mitochondria to the cytosol by the ABCB
transporter will be crucial to define whether a de novo synthesis
of [2Fe–2S] clusters is required in the cytosol.
In yeast, another proposed component of the ISC export
machinery is the sulfhydryl oxidase Erv1 located in the mito-
chondrial intermembrane space. This proposal is based on a
similar phenotype to that observed for Atm1 deficiency.224
However, it has been recently shown that the observed pheno-
type was a consequence of strongly decreased glutathione levels,
ruling out significant roles for Erv1 in cytosolic Fe–S protein
biogenesis and iron regulation.225
Concluding remarks
Recent research has greatly advanced our understanding of the
assembly and insertion of Fe–S clusters into mitochondrial,
cytosolic and nuclear target proteins in human cells. The
majority of the proteins involved in such processes have been
identified, but a complete picture of how they interact and work
at a molecular level is still ill-defined. The former steps of the
mitochondrial ISC assembly machinery devoted to the assembly
of a [2Fe–2S] cluster are best characterized at a molecular level.
Nevertheless, the high molecular complexity of the process still
does not provide a conclusive model on how [2Fe–2S] clusters are
assembled and on the specific role of all components that are
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exists in the late stages of the ISC assembly machinery. In
particular, the role of IBA57 is still not defined, and how the
[4Fe–4S] cluster assembled in mitochondria is inserted into
the final target proteins has to be understood. The most
relevant CIA machinery components in humans have been
identified, but a molecular picture of their function is still
largely missing. The available functional data do not provide a
clear view on how the CIA machinery components cooperate at
the molecular level. Even the numerous interactomic data
provided over the past few years are not conclusive in this
respect. The investigation of the interactions of the CIA com-
ponents at a molecular level and the associated structural data
are required to make a step forward on defining how the CIA
machinery works. We believe that this information will be
fundamental to understand the degree of dependence of the
CIA machinery on the ISC assembly and export machineries in
humans. Finally, the identification of the nature of the mole-
cule exported from mitochondria to the cytosol is a fundamental
step to be attained in order to define the role of the ISC isoforms
that are present in the cytosol in a de novo cytosolic synthesis
of [2Fe–2S] clusters. In conclusion, only a combination of
structural, biochemical and cell biological approaches can move
forward the understanding of the molecular mechanisms
responsible for the assembly and insertion of Fe–S clusters into
target proteins in humans.
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